Sr. Director, Compound Development Team Lead (CDTL)

At Genmab, we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.

Senior Director, Compound Development Team Leader

Genmab is seeking an experienced Compound Development Team Leader (CDTL) for our antibody product development programs. This is a leadership position within Genmab, accountable for driving the strategy and execution of 1-2 clinical stage development programs.  This position will be based in Princeton, NJ US with partial remote work.

The CDTL will drive the development and execution of compound strategy(ies), working in close partnership with the Vice President, Program Development Team Lead, when applicable. The CDTL will lead a cross-functional, matrixed team(s) to deliver against the program strategy. 

You will champion the program(s) at all levels of Genmab by providing clear communication, creative strategic approaches to development, and the ability to influence others.

This position reports to the Vice President, Program Development Team Lead.

Responsibilities

• Construct asset development plans through BLA approval by leading cross-functional efforts to evaluate mechanistic rationale, available data, competitive landscape, opportunity, regulatory precedence, and clinical study designs that deliver value.

  • Partner with Medical, Commercial, Regulatory, and Medical Affairs leaders on the CDT to problem solve and drive key workstreams balancing risk acceptability and expeditious delivery

  • Direct and redirect cross-functional efforts, prioritize workstreams, and/or identify subteam needs to ensure deliverables are aligned with the “big picture”

• Support the CDT by providing clear communication, eliminating obstacles, and driving efficiencies that enable on time delivery and promote effective Team performance

• Drive LCM strategies that support future value of a late stage asset through LoE

• Key contributor for all health authority engagements and externally facing efforts to “prepare the market” including publications, corporate communications, and advisory boards

  • Ensure CDT and Company goals are aligned across subteams and with individual team goals; coach and guide Team members and provide input on performance

• Continuous evaluation of CDT performance, capabilities, and needs; work with functional line management to secure required resource for project success and to influence optimal team composition

• Development Lead and face of Genmab for partnered programs ensuring development obligations within the collaboration are met, aligning on development strategy and driving joint decision making for the asset.

• Lead presentation and discussion for all Stage Gate decisions, updates, and communications to governance and leadership teams, aligning with Joint governance decision making as needed.

• Partner with Alliance Management on collaboration program requirements and communication needs.

• Accountable for overall budget and project plan deliverables, working closely with Project Management Team members to ensure alignment on budget, resource, and timelines.

• Partner with Project Management team member(s) to ensure execution against strategy, track progress, and communicate effectively within the team and organizationally.

Experience

• Bachelor’s degree in the life sciences is required; advanced degree is preferred

• Minimum of 12 years in the pharmaceutical/biotechnology industry

• Leadership of a cross-functional oncology drug development team with working knowledge across multiple R&D functions (preclinical, clinical, regulatory, CMC)

• Clinical development experience required; late-stage clinical experience is preferred

• Hands on BLA/NDA submission experience is preferred

• Solid business acumen and understanding of financial concepts

• Experience working within alliances or with collaboration partners

• Strategic agility: ability to pivot a team based on emerging and/or incomplete data, business drivers, or competitive landscape

• Independent ability to manage ambiguity and to translate the big picture into specific short- and long-term deliverables

• Demonstrated ability to influence and negotiate across the organization without direct reporting authority

• Excellent communication skills

This role is hybrid and requires you to be in the Princeton, NJ office 3x per week.

For US based candidates, the proposed salary band for this position is as follows:

The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as bonuses.

About You

• You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
• You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
• You are a generous collaborator who can work in teams with diverse backgrounds
• You are determined to do and be your best and take pride in enabling the best work of others on the team
• You are not afraid to grapple with the unknown and be innovative
• You have experience working in a fast-growing, dynamic company (or a strong desire to)
• You work hard and are not afraid to have a little fun while you do so

Locations

Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. 

Our commitment to diversity, equity, and inclusion

We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website. 

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website https://www.genmab.com/privacy.

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.